en.Wedoany.com Reported - Oberland Biotech GmbH has secured CHF 2.5 million in seed funding through a convertible note instrument. The round was backed by Kataria Holdings Ltd and executed under the supervision of the fund's overseer.

The company is primarily engaged in the international trade, sales, and export of nutritional supplements and food products, covering Switzerland and other international markets. Additionally, Oberland Biotech has established subsidiaries and branches globally through strategic partnerships and is involved in related projects in the food, nutrition, and biotechnology sectors.

The newly acquired funds will be used for product development, international business expansion, talent recruitment, and marketing and sales growth, accelerating its progress in key strategic directions. The company plans to strengthen its global presence, with a particular focus on the U.S. and Asian markets, while building a scalable business model within the biotechnology and nutrition ecosystem. Phillip Josef Jancer, CEO and founder of Oberland Biotech GmbH, stated that this funding represents a significant milestone in accelerating the development and scaling of innovative food and biotechnology solutions. With investor support, the company will be better positioned to achieve international expansion and enrich its product pipeline.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com